Preventing prescription opioid overdose deaths is a public health priority. Deaths from these medications exceed deaths from all illicit drugs combined.1 News reports, actions by states, and congressional legislation that single out the recently approved extended-release hydrocodone product Zohydro ER raise critical questions about the most effective policy needed to reverse the problem.
Jones CM, Lurie P, Woodcock J. Addressing Prescription Opioid Overdose: Data Support a Comprehensive Policy Approach. JAMA. 2014;312(17):1733–1734. doi:10.1001/jama.2014.13480
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: